Carbinoxamine Maleate Extended-Release Oral Suspension Drug Interactions
Carbinoxamine Maleate Extended-Release Oral Suspension (Carbinoxamine Maleate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Carbinoxamine Maleate Extended-Release Oral Suspension. Always confirm against the full prescribing information.
100 interactions
Acetazolamide
The risk or severity of CNS depression can be increased when Carbinoxamine is combined with Acetazolamide.
Level 2 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Carbinoxamine.
Level 2 evidence
Alfentanil
The risk or severity of CNS depression can be increased when Carbinoxamine is combined with Alfentanil.
Level 2 evidence
Almotriptan
The risk or severity of CNS depression can be increased when Carbinoxamine is combined with Almotriptan.
Level 2 evidence
Alosetron
The risk or severity of CNS depression can be increased when Carbinoxamine is combined with Alosetron.
Level 2 evidence
Alprazolam
The risk or severity of CNS depression can be increased when Alprazolam is combined with Carbinoxamine.
Level 2 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Amifampridine.
Level 2 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Amisulpride.
Level 1 evidence
Amitriptyline
The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Carbinoxamine.
Level 2 evidence
Amobarbital
The risk or severity of CNS depression can be increased when Carbinoxamine is combined with Amobarbital.
Level 2 evidence
Amoxapine
The risk or severity of CNS depression can be increased when Amoxapine is combined with Carbinoxamine.
Level 2 evidence
Amphetamine
Amphetamine may decrease the sedative activities of Carbinoxamine.
Level 1 evidence
Enter your NPI to unlock 9 major interactions for Carbinoxamine Maleate Extended-Release Oral Suspension
Carbinoxamine Maleate Extended-Release Oral Suspension (Carbinoxamine Maleate) has 462 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Carbinoxamine Maleate Extended-Release Oral Suspension (Carbinoxamine Maleate) has 49 major, 321 moderate, and 92 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Carbinoxamine Maleate Extended-Release Oral Suspension. Always confirm against the full prescribing information.